VI
CPRX

Vestcor Inc’s Catalyst Pharmaceutical CPRX Stock Holding History

Vestcor Inc’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Hold
33,670
– – 0.03% 537
2026
Q1 		$834K Buy
33,670
+10,190
+43% +$243K 0.02% 554
2025
Q4 		$548K Sell
23,480
-33,107
-59% -$737K 0.02% 679
2025
Q3 		$1.11M Sell
56,587
-5,060
-8% -$104K 0.03% 446
2025
Q2 		$1.34M Buy
61,647
+32,942
+115% +$778K 0.04% 407
2025
Q1 		$696K Buy
28,705
+840
+3% +$18.9K 0.02% 563
2024
Q4 		$582K Sell
27,865
-32,566
-54% -$700K 0.02% 621
2024
Q3 		$1.2M Buy
60,431
+9,379
+18% +$174K 0.04% 424
2024
Q2 		$791K Buy
51,052
+25,121
+97% +$391K 0.03% 497
2024
Q1 		$413K Sell
25,931
-32,937
-56% -$496K 0.01% 719
2023
Q4 		$990K Sell
58,868
-747
-1% -$10.2K 0.03% 447
2023
Q3 		$697K Buy
59,615
+7,942
+15% +$106K 0.03% 518
2023
Q2 		$694K Buy
51,673
+6,759
+15% +$97.3K 0.03% 523
2023
Q1 		$745K Hold
44,914
– – 0.03% 526
2022
Q4 		$835K Buy
44,914
+9,887
+28% +$152K 0.03% 517
2022
Q3 		$449K Hold
35,027
– – 0.02% 705
2022
Q2 		$246K Buy
+35,027
New +$257K 0.01% 857

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vestcor Inc's CPRX Position: Q2 2026 in Review

Vestcor Inc held its Catalyst Pharmaceutical (CPRX) position steady in Q2 2026 at 33,670 shares worth $1.06M. The position accounts for 0.03% of the portfolio, ranked #537.

Vestcor Inc first reported a position in CPRX in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.34M in Q2 2025. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Vestcor Inc held 33,670 shares of Catalyst Pharmaceutical worth $1.06M as of Q2 2026.
  • Vestcor Inc left its Catalyst Pharmaceutical share count unchanged in Q2 2026.
  • Catalyst Pharmaceutical made up 0.03% of Vestcor Inc's portfolio in Q2 2026, its #537 holding.
  • Vestcor Inc first reported a position in Catalyst Pharmaceutical in Q2 2022 and has held it in 17 quarters since.
  • Vestcor Inc's Catalyst Pharmaceutical position peaked at $1.34M in Q2 2025.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.